0000000000994134

AUTHOR

M. Koshiji Rosales

showing 2 related works from this author

P-138 Margetuximab combined with anti-PD-1 (retifanlimab) or anti-PD-1/LAG-3 (tebotelimab) +/- chemotherapy in first-line therapy of advanced/metasta…

2021

OncologyChemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentMargetuximabAnti pd 1CancerHematologymedicine.diseaseGastroesophageal JunctionFirst line therapyOncologyInternal medicinemedicinebusinessAnnals of Oncology
researchProduct

P-342 Margetuximab combined with anti-PD-1 (MGA012) or anti-PD-1/LAG-3 (MGD013) +/- chemotherapy in first-line therapy of advanced/metastatic HER2+ g…

2020

Oncologymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentMargetuximabAnti pd 1CancerHematologyGastroesophageal Junctionmedicine.diseaseFirst line therapyOncologyInternal medicinemedicinebusinessAnnals of Oncology
researchProduct